The stock for Amgen has sunk following the biotech company’s reveal of its obesity treatment’s early results. Sure enough, Amgen, also known as AMGN, is right behind Novo Nordisk (NVO) and Eli Lilly (LLY). The phase 1 study proved that ...
Tag: Amgen